We also suggested the p53-miR-138-AGO2 pathway as one mechanism underlying the high expression of AGO2 in a variety of highly invasive tumour tissues with silenced or mutant p53 expression, including myeloma, colon cancer, and liver cancer38–41. This evidence concerns the gene TP53 and colonic neoplasm.